SJ, B., Jr, B. D., WG, P., PB, S., D, G., MW, M., . . . CP, H. (2024). Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial. JAMA network open, 7(4), e247615. https://doi.org/10.1001/jamanetworkopen.2024.7615
Chicago Style (17th ed.) CitationSJ, Balevic, et al. "Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial." JAMA Network Open 7, no. 4 (2024): e247615. https://doi.org/10.1001/jamanetworkopen.2024.7615.
MLA (9th ed.) CitationSJ, Balevic, et al. "Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial." JAMA Network Open, vol. 7, no. 4, 2024, p. e247615, https://doi.org/10.1001/jamanetworkopen.2024.7615.